- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06898112
Mixed-methods Protocol for the WiSSPr Study (WiSSPr)
March 25, 2025 updated by: Centre for Infectious Disease Research in Zambia
Mixed-methods Protocol for the WiSSPr Study: Women in Sex Work, Stigma and Psychosocial Barriers to Pre-exposure Prophylaxis in Zambia
WiSSPr is a prospective observational cohort study grounded in community-based participatory research principles with a community advisory board (CAB) of key population (KP) civil society organi sations (KP-CSOs) and the Ministry of Health (MoH).
Study Overview
Detailed Description
WiSSPr is a prospective observational cohort study grounded in community-based participatory research principles with a community advisory board (CAB) of key population (KP) civil society organi sations (KP-CSOs) and the Ministry of Health (MoH).
We will administer a one-time psychosocial survey vetted by the CAB and follow 300 WESW in the electronic medical record for three months to measure PrEP initiation (#/% ever taking PrEP) and persistence (immediate discontinuation and a medication possession ratio).
We will conduct in-depth interviews with a purposive sample of 18 women, including 12 WESW and 6 peer navigators who support routine HIV screening and PrEP delivery, in two community hubs serving KPs since October 2021.
We seek to value KP communities as equal contributors to the knowledge production process by actively engaging KP-CSOs throughout the research process.
Expected outcomes include quantitative measures of PrEP initiation and persistence among WESW, and qualitative insights into the enablers and barriers to PrEP use informed by participants' lived experiences.
https://doi.org/10.1136/bmjopen-2023-080218
Study Type
Observational
Enrollment (Actual)
299
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lusaka, Zambia
- Centre for Infectious Disease Research Zambia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
The study population is composed of adult WESW who are living or working within the catchment areas of two community hubs located within urban Lusaka.
Based on CIDRZ's prior published work, we anticipate that the study population will be comprised largely (63%) of younger women (18 - 29 years old).
Description
Inclusion Criteria:
- Inclusion criteria: (1) identify as a cis-gendered or transgendered woman, (2) age ≥ 18 years, (3) earns a significant amount of income from exchanging sex for money or goods in the last 3 months, (4) HIV-negative status and eligible for PrEP according to national guidelines, (5) not planning to transfer care to another site within the next 30 days, (6) speaks English or ChiNyanja or IchiBemba and (7) willing and able to provide written informed consent
Exclusion Criteria:
- Exclusion criteria: (1) do not identify as a woman, (2) age < 18 years old, (3) has not earned a significant amount of income from exchanging sex for money or goods or has earned for < 3 months, (4) HIV-positive status or status is unknown or ineligible for PrEP, (5) planning to transfer care to another site within the next 30 days, (6) unable to speak English or ChiNyanja or IchiBemba and (7) not willing or able to provide written informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
PrEP initiators
women who initiate on PrEP
|
oral PrEP
|
|
PrEP refusers
women who refuse PrEP
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PrEP initiation (#/% ever taken PrEP)
Time Frame: 3 months
|
PrEP initiation (Number or percentage of Women Engaging in Sex Work (WESW) initiating on PrEP)
|
3 months
|
|
PrEP Persistence (#/ % eligible refills obtained until first discontinuation)
Time Frame: 3 months
|
PrEP persistence.
Number or percentage of women engaging in sex work with high levels of stigma who will persist on PrEP
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Ramya Kumar, PhD, MPH, University of Washington
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 18, 2023
Primary Completion (Actual)
March 31, 2024
Study Completion (Actual)
March 31, 2024
Study Registration Dates
First Submitted
March 11, 2025
First Submitted That Met QC Criteria
March 25, 2025
First Posted (Actual)
March 27, 2025
Study Record Updates
Last Update Posted (Actual)
March 27, 2025
Last Update Submitted That Met QC Criteria
March 25, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- UJMT Fogarty Fellowship 2023
- D43TW009340 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Vulnerable population of sex workers in a country where sex work is largely criminalized, and there is a risk of harm if the data is identifiable even with common identifiers like name is removed.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PrEP Uptake
-
The University of Texas Health Science Center,...Merck Sharp & Dohme LLCCompletedPrEP Uptake Perspectives | PrEP Uptake Experiences | PrEP Adherence Perspectives | PrEP Adherence ExperiencesUnited States
-
University of Alabama at BirminghamNational Institute of Mental Health (NIMH)CompletedPrEP UptakeUnited States
-
University of Alabama at BirminghamNational Institute of Mental Health (NIMH)RecruitingPrEP | HIV | HIV Prevention | PrEP UptakeUnited States
-
University of ChicagoNorthwestern University; Ann & Robert H Lurie Children's Hospital of Chicago; Howard Brown Health Center and other collaboratorsCompleted
-
Brown UniversityCompletedAdherence, Medication | Stimulant Abuse | PrEP UptakeUnited States
-
University of California, San DiegoCompletedHIV Seronegativity | PrEP UptakeUnited States
-
University of FloridaNational Institute on Drug Abuse (NIDA)Not yet recruitingDrug Use Disorders | PrEP Uptake | HIV Risk Behavior | PrEP Adherence
-
Yale UniversityGilead SciencesNot yet recruitingHIV Prevention | PrEP Uptake | PrEP AwarenessUnited States
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)RecruitingFeasibility | HIV Prevention | PrEP Uptake | Acceptability | HIV Self-testing | Male Partners of HIV-negative Postpartum WomenSouth Africa
Clinical Trials on PrEP
-
University of UlsterNorthern Ireland Chest Heart and StrokeCompleted
-
Medstar Health Research InstituteNational Institute of Mental Health (NIMH)CompletedHIV Prevention ProgramUnited States
-
Northwestern UniversityActive, not recruitingPrEP EducationUnited States
-
Penn State UniversityCompleted
-
University of WashingtonNational Institute of Allergy and Infectious Diseases (NIAID); Kenyatta National...Completed
-
San Diego State UniversityNational Institute of Mental Health (NIMH); Hennepin Healthcare Research InstituteCompleted
-
Heather HendersonUniversity of South Florida; Gilead Sciences; Tampa General HospitalNot yet recruitingPeople Who Inject Drugs | PrEP Adherence
-
Hilary L Surratt, PhDNational Institute on Drug Abuse (NIDA)CompletedHIV PreventionUnited States
-
University of Illinois at ChicagoNational Institute of Nursing Research (NINR)Active, not recruitingSex Work | Pre-Exposure ProphylaxisUnited States
-
University of California, San FranciscoNational Institute of Nursing Research (NINR); San Francisco Department of...CompletedHIV/AIDSUnited States